Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 3.040
-0.080 (-2.56%)
Feb 3, 2026, 11:06 AM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 1.02 billion as of February 3, 2026. Its market cap has increased by 17.29% in one year.
Market Cap
1.02B
Enterprise Value
409.25M
Revenue
73.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.04
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 1.02B, a decrease of -81.56%. That is a compound annual growth rate of -24.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.04B | 31.59% |
| Dec 30, 2025 | 787.63M | -20.81% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thor Medical ASA | 1.72B |
| ArcticZymes Technologies ASA | 1.13B |
| Lytix Biopharma AS | 711.84M |
| Zelluna ASA | 393.99M |
| Circio Holding ASA | 165.74M |
| SoftOx Solutions AS | 144.38M |
| EXACT Therapeutics AS | 117.67M |
| Arctic Bioscience AS | 93.00M |